Lee Coney

Lee Coney is an accomplished Senior Business Leader with extensive experience in scientific, strategic, commercial development, regulatory affairs, and management within the pharmaceutical and CRO sectors. Currently serving as Chief Scientific Officer at Sequani since May 2023, Lee has held prominent roles including Head of Development and Head of Non-Clinical Safety at Cell and Gene Therapy Catapult from February 2020 to May 2023. Previous positions include Chief Scientific Officer at Envigo, Director of Biopharmaceutical Development at Huntingdon Life Sciences, and Product Development Manager at CellFactors, among others. Lee holds a BSc in Microbiology from the University of East London and possesses a strong passion for enhancing operations and fostering talent to achieve sustainable productivity gains.